NH2-terminal BH4 Domain of Bcl-2 Is Functional for Heterodimerization with Bax and Inhibition of Apoptosis

This publication has 35 references indexed in Scilit:

• Mutagenesis of the BH3 Domain of BAX Identifies Residues Critical for Dimerization and Killing
  Molecular and Cellular Biology, 1998
• Caspases: killer proteases
  Trends in Biochemical Sciences, 1997
• The proto-oncogene Bcl-2 and its role in regulating apoptosis
  Nature Medicine, 1997
• Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2
  Journal of Biological Chemistry, 1996
• New members of the Bcl-2 family and their protein partners
  Current Opinion in Genetics & Development, 1996
• Multiple Bcl-2 family members demonstrate selective dimerizations with Bax.
  Proceedings of the National Academy of Sciences, 1995
• Apoptosis in the Pathogenesis and Treatment of Disease
  Science, 1995
• Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system.
  Proceedings of the National Academy of Sciences, 1994
• BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
  Nature, 1994
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
  Cell, 1993